SlideShare a Scribd company logo
name: Stéphane LUCCHINI    sex: male
address: 9 Les bastides de Thouron 13360 Roquevaire France   nationality: French
telephone: +33 6 63 94 10 40    date of birth: 26/05/66
email: stephane.lucchini@me.com    marital status: married, 2 daughters
MISSION & CAREER OBJECTIVE
Global Buysiness Development & Absolute Customer Satisfaction
SKILLS, COMPETENCIES & VALUES
• strategy development & company organisation
• team building & management
• strong interpersonal & communication skills
• entrepreneurial spirit, creativity & innovation
• integrity, rigour, flexibility & continuous learning
CURRENT RESPONSIBILITIES
• director of the generics/supergenerics business unit (new products development, project
management, sales, marketing & communications)
• leading scientific and technical teams, project management
• strategic positioning and orientation, risk-analysis, ROI/rNPV, marketing & promotions
• technology development & applications (injectables): CNS, pain, woman health, oncology,
diabetes...
• market analysis & competitive analysis: DDS companies, KOLs (MDs, surgeons, foundations, etc.)
• sales (proof of concept studies up to €1m, drug development & licensing-out up to €50m)
• overseas business development (Europe, USA, LATAM, MENA, CIS countries, Japan, Australia)
• client needs analysis, development of customised solutions, quotations
• research agreement & licensing-out negotiation (contract terms, milestones & royalties structure)
• CRM (customer relationship management) & relationship-building
• development of partnerships & collaborations (generic & pharmaceutical companies)
• after-sales support (final contracts & amendments, customer satisfaction analysis…)
• strategic partnerships set-up: strategic and tactical planning processes, execution
EXPERIENCE & SPECIALITIES
• 15y+ International business development and licensing-out
• supergenerics, value added generics, NTEs & emerging markets
• injectables, innovative drug delivery, long-acting formulations (depot)
• founder of two preclinical services companies, biomarker services company restructuring
• direct experience in the identification & establishment of new business
• 2900+ LinkedIn contacts, 6000+ contacts in the pharmaceutical/generic industry
c u r r i c u l u m v i t a e
s t é p h a n e l u c c h i n i
PROFESSIONAL EXPERIENCE
2010 - today Business Director, Generics/Supergenerics Business Unit, MedinCell SA
(Drug Delivery Company; controlled long-acting formulations)
2007 - 2010 Business Director, Biovays SAS (biomarker solutions)
2000 - 2007 Founder and Senior Partner, Syncrosome SAS (pre-clinical CRO)
Customer Service Manager, Syncrosome SAS
1996 - 2000 Founder of SCP des Drs Abysique & Lucchini (pre-clinical CRO)
FURTHER EDUCATION
2005 - 2006 CEGOS, Paris
Master degree in Business
1991 - 1994 Public Centre of Scientific Research (CNRS), Marseille
PhD in Neurobiology & Biochemistry
1990 Aix-Marseille University, Marseille
Master degree in Research (Biological Science)
LANGUAGES
• French: mother tongue
• English: fluent written and spoken
OTHER
• member of AAPS (American Association for Pharmaceutical Science)
• member of DIA (Drug Information Association)
• member of AALAS (American Association for Laboratory Animal Science)
• member of AFSTAL (French Association for Sciences and Techniques for Laboratory Animals)
• French license for in vivo experimentation & study management
• French license for surgeries in numerous species (rodents, primates, pig, cat, dog, rabbit, sheep…)
• computer literate (Mac & Microsoft environments, DTP, Pharma databases, CRM & research tools)
INTERESTS
• pedestrian excursions & travel, cinema, reading, jazz
c u r r i c u l u m v i t a e
s t é p h a n e l u c c h i n i

More Related Content

Similar to Lucchini cv june 2013

International marketing Marketing Decisions on marketing MIX
International marketing Marketing Decisions on marketing MIXInternational marketing Marketing Decisions on marketing MIX
International marketing Marketing Decisions on marketing MIX
Dhanushka Bandara
 
Eyeforpharma 2016 barcelona
Eyeforpharma 2016 barcelonaEyeforpharma 2016 barcelona
Eyeforpharma 2016 barcelona
Jon Stig Møller Kristensen
 
Patrick Simekha resume new (1)
Patrick Simekha resume new (1)Patrick Simekha resume new (1)
Patrick Simekha resume new (1)
Patrick Simekha
 
Roche Diagnostics
Roche DiagnosticsRoche Diagnostics
Roche Diagnostics
love4mihir
 
How Can Pharma Companies Boost Preclinical Trial Success?
How Can Pharma Companies Boost Preclinical Trial Success?How Can Pharma Companies Boost Preclinical Trial Success?
How Can Pharma Companies Boost Preclinical Trial Success?
Life Sciences Network marcus evans
 
Vivid Provider Mini Capabilities 2009
Vivid Provider Mini Capabilities 2009Vivid Provider Mini Capabilities 2009
Vivid Provider Mini Capabilities 2009
lillianthiemann
 
CTSC 16
CTSC 16CTSC 16
CTSC 16
amin ahmed
 
Clinical Trial Supply
Clinical Trial SupplyClinical Trial Supply
Clinical Trial Supply
Abdul Jamad
 
SMi Group's Inaugural Big Data in Pharma conference
SMi Group's Inaugural Big Data in Pharma conferenceSMi Group's Inaugural Big Data in Pharma conference
SMi Group's Inaugural Big Data in Pharma conference
Dale Butler
 
cv business
cv businesscv business
cv business
klaas vandevyvere
 
John Hickey CV 072216
John Hickey CV 072216John Hickey CV 072216
John Hickey CV 072216
John Hickey
 
Sample0208 3
Sample0208 3Sample0208 3
Sample0208 3
SkyeCreativeMedia
 
IMS Health Real-World Evidence Brochure
IMS Health Real-World Evidence BrochureIMS Health Real-World Evidence Brochure
IMS Health Real-World Evidence Brochure
IMSHealthRWES
 
An interview with ucb’s jean christophe tellier-heidrick & struggles
An interview with ucb’s jean christophe tellier-heidrick & strugglesAn interview with ucb’s jean christophe tellier-heidrick & struggles
An interview with ucb’s jean christophe tellier-heidrick & struggles
Niren Thanky
 
Putting the patient first in pharma, an interview with ucb’s jean christophe ...
Putting the patient first in pharma, an interview with ucb’s jean christophe ...Putting the patient first in pharma, an interview with ucb’s jean christophe ...
Putting the patient first in pharma, an interview with ucb’s jean christophe ...
Niren Thanky
 
Talent Brochure Werfen
Talent Brochure WerfenTalent Brochure Werfen
Talent Brochure Werfen
Patrick V. Ulrich
 
The 10 Most Innovative Pharma and Biotech Solution Providers, 2020 September ...
The 10 Most Innovative Pharma and Biotech Solution Providers, 2020 September ...The 10 Most Innovative Pharma and Biotech Solution Providers, 2020 September ...
The 10 Most Innovative Pharma and Biotech Solution Providers, 2020 September ...
Merry D'souza
 
Hoffman la roche business review.pptx
Hoffman la roche business review.pptxHoffman la roche business review.pptx
Hoffman la roche business review.pptx
Marina Ibrahim
 
7th annual clinical trials summit 2016
7th annual clinical trials summit 20167th annual clinical trials summit 2016
7th annual clinical trials summit 2016
Deepak Raj (2,000+Connections)
 
Corporate Overview
Corporate OverviewCorporate Overview
Corporate Overview
Magdalena Kozuszek Assoc CIPD
 

Similar to Lucchini cv june 2013 (20)

International marketing Marketing Decisions on marketing MIX
International marketing Marketing Decisions on marketing MIXInternational marketing Marketing Decisions on marketing MIX
International marketing Marketing Decisions on marketing MIX
 
Eyeforpharma 2016 barcelona
Eyeforpharma 2016 barcelonaEyeforpharma 2016 barcelona
Eyeforpharma 2016 barcelona
 
Patrick Simekha resume new (1)
Patrick Simekha resume new (1)Patrick Simekha resume new (1)
Patrick Simekha resume new (1)
 
Roche Diagnostics
Roche DiagnosticsRoche Diagnostics
Roche Diagnostics
 
How Can Pharma Companies Boost Preclinical Trial Success?
How Can Pharma Companies Boost Preclinical Trial Success?How Can Pharma Companies Boost Preclinical Trial Success?
How Can Pharma Companies Boost Preclinical Trial Success?
 
Vivid Provider Mini Capabilities 2009
Vivid Provider Mini Capabilities 2009Vivid Provider Mini Capabilities 2009
Vivid Provider Mini Capabilities 2009
 
CTSC 16
CTSC 16CTSC 16
CTSC 16
 
Clinical Trial Supply
Clinical Trial SupplyClinical Trial Supply
Clinical Trial Supply
 
SMi Group's Inaugural Big Data in Pharma conference
SMi Group's Inaugural Big Data in Pharma conferenceSMi Group's Inaugural Big Data in Pharma conference
SMi Group's Inaugural Big Data in Pharma conference
 
cv business
cv businesscv business
cv business
 
John Hickey CV 072216
John Hickey CV 072216John Hickey CV 072216
John Hickey CV 072216
 
Sample0208 3
Sample0208 3Sample0208 3
Sample0208 3
 
IMS Health Real-World Evidence Brochure
IMS Health Real-World Evidence BrochureIMS Health Real-World Evidence Brochure
IMS Health Real-World Evidence Brochure
 
An interview with ucb’s jean christophe tellier-heidrick & struggles
An interview with ucb’s jean christophe tellier-heidrick & strugglesAn interview with ucb’s jean christophe tellier-heidrick & struggles
An interview with ucb’s jean christophe tellier-heidrick & struggles
 
Putting the patient first in pharma, an interview with ucb’s jean christophe ...
Putting the patient first in pharma, an interview with ucb’s jean christophe ...Putting the patient first in pharma, an interview with ucb’s jean christophe ...
Putting the patient first in pharma, an interview with ucb’s jean christophe ...
 
Talent Brochure Werfen
Talent Brochure WerfenTalent Brochure Werfen
Talent Brochure Werfen
 
The 10 Most Innovative Pharma and Biotech Solution Providers, 2020 September ...
The 10 Most Innovative Pharma and Biotech Solution Providers, 2020 September ...The 10 Most Innovative Pharma and Biotech Solution Providers, 2020 September ...
The 10 Most Innovative Pharma and Biotech Solution Providers, 2020 September ...
 
Hoffman la roche business review.pptx
Hoffman la roche business review.pptxHoffman la roche business review.pptx
Hoffman la roche business review.pptx
 
7th annual clinical trials summit 2016
7th annual clinical trials summit 20167th annual clinical trials summit 2016
7th annual clinical trials summit 2016
 
Corporate Overview
Corporate OverviewCorporate Overview
Corporate Overview
 

Recently uploaded

Science Around Us Module 2 Matter Around Us
Science Around Us Module 2 Matter Around UsScience Around Us Module 2 Matter Around Us
Science Around Us Module 2 Matter Around Us
PennapaKeavsiri
 
Kalyan Chart Satta Matka Dpboss Kalyan Matka Results
Kalyan Chart Satta Matka Dpboss Kalyan Matka ResultsKalyan Chart Satta Matka Dpboss Kalyan Matka Results
Kalyan Chart Satta Matka Dpboss Kalyan Matka Results
Satta Matka Dpboss Kalyan Matka Results
 
Efficient PHP Development Solutions for Dynamic Web Applications
Efficient PHP Development Solutions for Dynamic Web ApplicationsEfficient PHP Development Solutions for Dynamic Web Applications
Efficient PHP Development Solutions for Dynamic Web Applications
Harwinder Singh
 
1 Circular 003_2023 ISO 27001_2022 Transition Arrangments v3.pdf
1 Circular 003_2023 ISO 27001_2022 Transition Arrangments v3.pdf1 Circular 003_2023 ISO 27001_2022 Transition Arrangments v3.pdf
1 Circular 003_2023 ISO 27001_2022 Transition Arrangments v3.pdf
ISONIKELtd
 
PDT 99 - $3.5M - Seed - Feel Therapeutics.pdf
PDT 99 - $3.5M - Seed - Feel Therapeutics.pdfPDT 99 - $3.5M - Seed - Feel Therapeutics.pdf
PDT 99 - $3.5M - Seed - Feel Therapeutics.pdf
HajeJanKamps
 
list of states and organizations .pdf
list of  states  and  organizations .pdflist of  states  and  organizations .pdf
list of states and organizations .pdf
Rbc Rbcua
 
NIMA2024 | De toegevoegde waarde van DEI en ESG in campagnes | Nathalie Lam |...
NIMA2024 | De toegevoegde waarde van DEI en ESG in campagnes | Nathalie Lam |...NIMA2024 | De toegevoegde waarde van DEI en ESG in campagnes | Nathalie Lam |...
NIMA2024 | De toegevoegde waarde van DEI en ESG in campagnes | Nathalie Lam |...
BBPMedia1
 
❽❽❻❼❼❻❻❸❾❻ DPBOSS NET SPBOSS SATTA MATKA RESULT KALYAN MATKA GUESSING FREE KA...
❽❽❻❼❼❻❻❸❾❻ DPBOSS NET SPBOSS SATTA MATKA RESULT KALYAN MATKA GUESSING FREE KA...❽❽❻❼❼❻❻❸❾❻ DPBOSS NET SPBOSS SATTA MATKA RESULT KALYAN MATKA GUESSING FREE KA...
❽❽❻❼❼❻❻❸❾❻ DPBOSS NET SPBOSS SATTA MATKA RESULT KALYAN MATKA GUESSING FREE KA...
essorprof62
 
Registered-Establishment-List-in-Uttarakhand-pdf.pdf
Registered-Establishment-List-in-Uttarakhand-pdf.pdfRegistered-Establishment-List-in-Uttarakhand-pdf.pdf
Registered-Establishment-List-in-Uttarakhand-pdf.pdf
dazzjoker
 
High-Quality IPTV Monthly Subscription for $15
High-Quality IPTV Monthly Subscription for $15High-Quality IPTV Monthly Subscription for $15
High-Quality IPTV Monthly Subscription for $15
advik4387
 
TriStar Gold Corporate Presentation - June 2024
TriStar Gold Corporate Presentation - June 2024TriStar Gold Corporate Presentation - June 2024
TriStar Gold Corporate Presentation - June 2024
Adnet Communications
 
Prescriptive analytics BA4206 Anna University PPT
Prescriptive analytics BA4206 Anna University PPTPrescriptive analytics BA4206 Anna University PPT
Prescriptive analytics BA4206 Anna University PPT
Freelance
 
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan ChartSatta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results
 
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan ChartSatta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results
 
Enhancing Adoption of AI in Agri-food: Introduction
Enhancing Adoption of AI in Agri-food: IntroductionEnhancing Adoption of AI in Agri-food: Introduction
Enhancing Adoption of AI in Agri-food: Introduction
Cor Verdouw
 
Adani Group's Active Interest In Increasing Its Presence in the Cement Manufa...
Adani Group's Active Interest In Increasing Its Presence in the Cement Manufa...Adani Group's Active Interest In Increasing Its Presence in the Cement Manufa...
Adani Group's Active Interest In Increasing Its Presence in the Cement Manufa...
Adani case
 
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan ChartSatta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results
 
The Steadfast and Reliable Bull: Taurus Zodiac Sign
The Steadfast and Reliable Bull: Taurus Zodiac SignThe Steadfast and Reliable Bull: Taurus Zodiac Sign
The Steadfast and Reliable Bull: Taurus Zodiac Sign
my Pandit
 
Unlocking WhatsApp Marketing with HubSpot: Integrating Messaging into Your Ma...
Unlocking WhatsApp Marketing with HubSpot: Integrating Messaging into Your Ma...Unlocking WhatsApp Marketing with HubSpot: Integrating Messaging into Your Ma...
Unlocking WhatsApp Marketing with HubSpot: Integrating Messaging into Your Ma...
Niswey
 
Cover Story - China's Investment Leader - Dr. Alyce SU
Cover Story - China's Investment Leader - Dr. Alyce SUCover Story - China's Investment Leader - Dr. Alyce SU
Cover Story - China's Investment Leader - Dr. Alyce SU
msthrill
 

Recently uploaded (20)

Science Around Us Module 2 Matter Around Us
Science Around Us Module 2 Matter Around UsScience Around Us Module 2 Matter Around Us
Science Around Us Module 2 Matter Around Us
 
Kalyan Chart Satta Matka Dpboss Kalyan Matka Results
Kalyan Chart Satta Matka Dpboss Kalyan Matka ResultsKalyan Chart Satta Matka Dpboss Kalyan Matka Results
Kalyan Chart Satta Matka Dpboss Kalyan Matka Results
 
Efficient PHP Development Solutions for Dynamic Web Applications
Efficient PHP Development Solutions for Dynamic Web ApplicationsEfficient PHP Development Solutions for Dynamic Web Applications
Efficient PHP Development Solutions for Dynamic Web Applications
 
1 Circular 003_2023 ISO 27001_2022 Transition Arrangments v3.pdf
1 Circular 003_2023 ISO 27001_2022 Transition Arrangments v3.pdf1 Circular 003_2023 ISO 27001_2022 Transition Arrangments v3.pdf
1 Circular 003_2023 ISO 27001_2022 Transition Arrangments v3.pdf
 
PDT 99 - $3.5M - Seed - Feel Therapeutics.pdf
PDT 99 - $3.5M - Seed - Feel Therapeutics.pdfPDT 99 - $3.5M - Seed - Feel Therapeutics.pdf
PDT 99 - $3.5M - Seed - Feel Therapeutics.pdf
 
list of states and organizations .pdf
list of  states  and  organizations .pdflist of  states  and  organizations .pdf
list of states and organizations .pdf
 
NIMA2024 | De toegevoegde waarde van DEI en ESG in campagnes | Nathalie Lam |...
NIMA2024 | De toegevoegde waarde van DEI en ESG in campagnes | Nathalie Lam |...NIMA2024 | De toegevoegde waarde van DEI en ESG in campagnes | Nathalie Lam |...
NIMA2024 | De toegevoegde waarde van DEI en ESG in campagnes | Nathalie Lam |...
 
❽❽❻❼❼❻❻❸❾❻ DPBOSS NET SPBOSS SATTA MATKA RESULT KALYAN MATKA GUESSING FREE KA...
❽❽❻❼❼❻❻❸❾❻ DPBOSS NET SPBOSS SATTA MATKA RESULT KALYAN MATKA GUESSING FREE KA...❽❽❻❼❼❻❻❸❾❻ DPBOSS NET SPBOSS SATTA MATKA RESULT KALYAN MATKA GUESSING FREE KA...
❽❽❻❼❼❻❻❸❾❻ DPBOSS NET SPBOSS SATTA MATKA RESULT KALYAN MATKA GUESSING FREE KA...
 
Registered-Establishment-List-in-Uttarakhand-pdf.pdf
Registered-Establishment-List-in-Uttarakhand-pdf.pdfRegistered-Establishment-List-in-Uttarakhand-pdf.pdf
Registered-Establishment-List-in-Uttarakhand-pdf.pdf
 
High-Quality IPTV Monthly Subscription for $15
High-Quality IPTV Monthly Subscription for $15High-Quality IPTV Monthly Subscription for $15
High-Quality IPTV Monthly Subscription for $15
 
TriStar Gold Corporate Presentation - June 2024
TriStar Gold Corporate Presentation - June 2024TriStar Gold Corporate Presentation - June 2024
TriStar Gold Corporate Presentation - June 2024
 
Prescriptive analytics BA4206 Anna University PPT
Prescriptive analytics BA4206 Anna University PPTPrescriptive analytics BA4206 Anna University PPT
Prescriptive analytics BA4206 Anna University PPT
 
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan ChartSatta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
 
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan ChartSatta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
 
Enhancing Adoption of AI in Agri-food: Introduction
Enhancing Adoption of AI in Agri-food: IntroductionEnhancing Adoption of AI in Agri-food: Introduction
Enhancing Adoption of AI in Agri-food: Introduction
 
Adani Group's Active Interest In Increasing Its Presence in the Cement Manufa...
Adani Group's Active Interest In Increasing Its Presence in the Cement Manufa...Adani Group's Active Interest In Increasing Its Presence in the Cement Manufa...
Adani Group's Active Interest In Increasing Its Presence in the Cement Manufa...
 
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan ChartSatta Matka Dpboss Kalyan Matka Results Kalyan Chart
Satta Matka Dpboss Kalyan Matka Results Kalyan Chart
 
The Steadfast and Reliable Bull: Taurus Zodiac Sign
The Steadfast and Reliable Bull: Taurus Zodiac SignThe Steadfast and Reliable Bull: Taurus Zodiac Sign
The Steadfast and Reliable Bull: Taurus Zodiac Sign
 
Unlocking WhatsApp Marketing with HubSpot: Integrating Messaging into Your Ma...
Unlocking WhatsApp Marketing with HubSpot: Integrating Messaging into Your Ma...Unlocking WhatsApp Marketing with HubSpot: Integrating Messaging into Your Ma...
Unlocking WhatsApp Marketing with HubSpot: Integrating Messaging into Your Ma...
 
Cover Story - China's Investment Leader - Dr. Alyce SU
Cover Story - China's Investment Leader - Dr. Alyce SUCover Story - China's Investment Leader - Dr. Alyce SU
Cover Story - China's Investment Leader - Dr. Alyce SU
 

Lucchini cv june 2013

  • 1. name: Stéphane LUCCHINI    sex: male address: 9 Les bastides de Thouron 13360 Roquevaire France   nationality: French telephone: +33 6 63 94 10 40    date of birth: 26/05/66 email: stephane.lucchini@me.com    marital status: married, 2 daughters MISSION & CAREER OBJECTIVE Global Buysiness Development & Absolute Customer Satisfaction SKILLS, COMPETENCIES & VALUES • strategy development & company organisation • team building & management • strong interpersonal & communication skills • entrepreneurial spirit, creativity & innovation • integrity, rigour, flexibility & continuous learning CURRENT RESPONSIBILITIES • director of the generics/supergenerics business unit (new products development, project management, sales, marketing & communications) • leading scientific and technical teams, project management • strategic positioning and orientation, risk-analysis, ROI/rNPV, marketing & promotions • technology development & applications (injectables): CNS, pain, woman health, oncology, diabetes... • market analysis & competitive analysis: DDS companies, KOLs (MDs, surgeons, foundations, etc.) • sales (proof of concept studies up to €1m, drug development & licensing-out up to €50m) • overseas business development (Europe, USA, LATAM, MENA, CIS countries, Japan, Australia) • client needs analysis, development of customised solutions, quotations • research agreement & licensing-out negotiation (contract terms, milestones & royalties structure) • CRM (customer relationship management) & relationship-building • development of partnerships & collaborations (generic & pharmaceutical companies) • after-sales support (final contracts & amendments, customer satisfaction analysis…) • strategic partnerships set-up: strategic and tactical planning processes, execution EXPERIENCE & SPECIALITIES • 15y+ International business development and licensing-out • supergenerics, value added generics, NTEs & emerging markets • injectables, innovative drug delivery, long-acting formulations (depot) • founder of two preclinical services companies, biomarker services company restructuring • direct experience in the identification & establishment of new business • 2900+ LinkedIn contacts, 6000+ contacts in the pharmaceutical/generic industry c u r r i c u l u m v i t a e s t é p h a n e l u c c h i n i
  • 2. PROFESSIONAL EXPERIENCE 2010 - today Business Director, Generics/Supergenerics Business Unit, MedinCell SA (Drug Delivery Company; controlled long-acting formulations) 2007 - 2010 Business Director, Biovays SAS (biomarker solutions) 2000 - 2007 Founder and Senior Partner, Syncrosome SAS (pre-clinical CRO) Customer Service Manager, Syncrosome SAS 1996 - 2000 Founder of SCP des Drs Abysique & Lucchini (pre-clinical CRO) FURTHER EDUCATION 2005 - 2006 CEGOS, Paris Master degree in Business 1991 - 1994 Public Centre of Scientific Research (CNRS), Marseille PhD in Neurobiology & Biochemistry 1990 Aix-Marseille University, Marseille Master degree in Research (Biological Science) LANGUAGES • French: mother tongue • English: fluent written and spoken OTHER • member of AAPS (American Association for Pharmaceutical Science) • member of DIA (Drug Information Association) • member of AALAS (American Association for Laboratory Animal Science) • member of AFSTAL (French Association for Sciences and Techniques for Laboratory Animals) • French license for in vivo experimentation & study management • French license for surgeries in numerous species (rodents, primates, pig, cat, dog, rabbit, sheep…) • computer literate (Mac & Microsoft environments, DTP, Pharma databases, CRM & research tools) INTERESTS • pedestrian excursions & travel, cinema, reading, jazz c u r r i c u l u m v i t a e s t é p h a n e l u c c h i n i